CCL3 and neoplasm: Next, we intravenously inoculated 5TGM1 cells into the mice and treated them with either control IgG or neutralizing antibodies against CCL3 or CCL2 (100 μg per mouse each time, intraperitoneally injected 1 day before and 7 days after tumor cell inoculation; Figure 4B).